Synthekine is an engineered cytokine therapeutics company developing disease-optimized treatments. The company uses immunological insights to guide targeted protein engineering to generate transformative medicines for cancer and autoimmune disorders. Using the principles of cytokine partial agonism and immunological specificity, Synthekine designs differentiated therapeutics to be both safe and efficacious. Its lead programs have shown promising efficacy and tolerability in preclinical studies, and it is developing additional cytokine partial agonists that selectively modulate key pathways of the immune system.
| Website | http://www.synthekine.com |
| Revenue | $16.9 million |
| Employees | 54 (51 on RocketReach) |
| Founded | 2018 |
| Address | 1505 OBrien Dr, Menlo Park, California 94025, US |
| Phone | +1 650-271-9888 |
| Technologies |
JavaScript
,
HTML
,
PHP
+9 more
(view full list)
|
| Industry | Biotechnology Research, Drug Discovery, Biotechnology |
| Keywords | Therapeutic Proteins, Cancer Therapeutics, Biopharmaceutical Development, Protein Engineering, Immuno-Oncology, Immunology Research, Drug Development, Biotechnology, Pharmaceutical Research, Clinical Trials, Biologics, Therapeutic Antibodies, Precision Medicine, Drug Discovery |
| Competitors | Roche, Novartis, The Janssen Pharmaceutical Companies of Johnson & Johnson, AbbVie, Merck & Co., Inc., Pfizer, Bristol Myers Squibb, Genentech, Amgen, Gilead Sciences +42 more (view full list) |
Looking for a particular Synthekine employee's phone or email?
The Synthekine annual revenue was $16.9 million in 2026.
Greg Yedinak is the CTO of Synthekine.
51 people are employed at Synthekine.
Synthekine is based in Menlo Park, California.